Tag: prostate
Five-year outcomes show transurethral ultrasound ablation successful in treatment of prostate...
A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research...
AngioDynamics completes enrolment for PRESERVE clinical study
AngioDynamics has announced the completion of enrolment and final treatment in its pivotal study of the NanoKnife system for ablation of prostate tissue in...
The Lancet-published study finds “PAE provides more urinary and sexual symptom...
A French group of interventional radiologists and urologists has recently published the results of its randomised, multicentre, open-label, phase 3 superiority trial of prostate...
Profound Medical announces new CPT category 1 codes for prostate TULSA
Profound Medical has announced in a press release that, with sponsorship and support from multiple physician specialty societies, the American Medical Association (AMA) has...
Study finds PAE “highly effective” long-term treatment for enlarged prostate
Prostate artery embolization (PAE) provides long-term effectiveness in treating urinary symptoms from an enlarged prostate gland, according to new research to be presented at...
Teleflex announces collaboration with FundamentalVR to improve training through virtual reality...
Teleflex has announced a new agreement with FundamentalVR, a company providing virtual reality (VR) integration for medical simulation. The agreement will provide Teleflex with...
“Promising” 10-year findings on PAE for BPH presented at ET 2022
Tiago Bilhim (Saint Louis Hospital, Lisbon, Portugal) presented during the Scientific Paper session at this year’s European Conference on Embolotherapy (22–25 June, Nice, France),...
New data reinforce efficacy of the UroLift system for the treatment...
Teleflex has announced the results of several research studies that further support the safety and efficacy of the UroLift system for men living with...
Teleflex completes acquisition of UroLift creator, NeoTract
Teleflex has announced the completion of its previously announced acquisition of NeoTract.
Founded in 2004, NeoTract is a privately-held medical device company that has developed...
Augmenix announces first prostate cancer patients treated with SpaceOAR hydrogel in...
Augmenix, a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during radiotherapy and interventional...
Embosphere receives US FDA de novo classification for prostatic artery embolization
Merit Medical has announced that it has received 513(f)(2) (de novo) classification from the FDA to expand indication for its Embosphere microspheres. The indication...
High radiation dose to operator with prostatic artery embolization, until imaging...
According to our results, the physician who performs prostatic artery embolization procedures, even with a ceiling suspended shield, would reach the annual radiation limit...
1,000-patient study indicates prostate artery embolization remains effective for years
Prostate artery embolization maintains its effectiveness for at least three years after patients undergo the therapy, according to research presented at the Society of...
Mentice releases world’s first endovascular simulation training software module for prostatic...
Mentice has announced the release of the world’s first simulation training software module for prostatic artery embolization. The software, created from real patients’ data,...
